COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES
The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research and policy including ethics, medical product development and safety. CIOMS is in official relations with WHO and is an associate partner of UNESCO.
MoreCioms news
RECENT PUBLICATIONS
The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research including ethics, medical product development and safety.
Please visit shop
CIOMS WORKING GROUPS
The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include many of the biomedical disciplines, national academies of sciences and medical research councils. CIOMS mission is to advance public health through guidance on health research including ethics, medical product development and safety.
The current and recent Working Groups
- Working Group XIV Artificial Intelligence in Pharmacovigilance
- Good Governance Practice for Research Institutions
- Recommended Standards of Education and Training for Health Professionals Participating in Medicines Development
- Severe Cutaneous Adverse Reactions to Drugs – SCAR
- Working Group XIII – Real-World Data and Real-World Evidence in Regulatory Decision Making
- Working Group XII – Benefit-Risk Balance for Medicinal Products
- MedDRA Labelling Groupings
CIOMS MEETINGS
Upcoming Meetings
12 April 2023
Virtual
4th Meeting for the Working Group on Artificial Intelligence in Pharmacovigilance
23 May 2023
Virtual
10th meeting of the WG XII on Benefit-Risk Balance for Medicinal Products
30 May 2023
Virtual
17th meeting of the Working Group XIII on Real-World Data & Evidence in Regulatory Decision-Making
06 - 07 June 2023
Zurich, Switzerland
5th Meeting for the Working Group on Artificial Intelligence in Pharmacovigilance
Recent Meetings
Member Organizations
